Brevan Howard Capital Management’s Abbott ABT Stock Holding History

Brevan Howard Capital Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$764K	Sell	8,416 -7,571	-47%	-$691K	0.01%	1216
2026 Q1	$1.64M	Buy	15,987 +10,092	+171%	+$1.14M	0.01%	650
2025 Q4	$739K	Sell	5,895 -797	-12%	-$102K	0.01%	909
2025 Q3	$896K	Sell	6,692 -39,083	-85%	-$5.13M	﹤0.01%	954
2025 Q2	$6.23M	Sell	45,775 -6,865	-13%	-$905K	0.04%	296
2025 Q1	$6.98M	Buy	+52,640	New	+$6.7M	0.07%	91
2024 Q4	–	Sell	-28,573	Closed	-$3.26M	–	999
2024 Q3	$3.26M	Sell	28,573 -2,602	-8%	-$285K	0.02%	178
2024 Q2	$3.24M	Buy	+31,175	New	+$3.31M	0.03%	134
2024 Q1	–	Sell	-7,089	Closed	-$780K	–	964
2023 Q4	$780K	Buy	+7,089	New	+$708K	0.01%	313

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Brevan Howard Capital Management's ABT Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Abbott (ABT) stake by 47% in Q2 2026, selling an estimated $691K and leaving 8,416 shares worth $764K. The position accounts for 0.01% of the portfolio, ranked #1216.

Brevan Howard Capital Management first reported a position in ABT in Q4 2023 and has held it in 9 quarters since. The position peaked at $6.98M in Q1 2025. 2,982 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Brevan Howard Capital Management held 8,416 shares of Abbott worth $764K as of Q2 2026.
Brevan Howard Capital Management sold 7,571 Abbott shares in Q2 2026, an estimated $691K.
Abbott made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1216 holding.
Brevan Howard Capital Management first reported a position in Abbott in Q4 2023 and has held it in 9 quarters since.
Brevan Howard Capital Management's Abbott position peaked at $6.98M in Q1 2025.
2,982 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.